1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine has been researched along with mesulergine in 1 studies
| Studies (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Trials (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Recent Studies (post-2010) (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Studies (mesulergine) | Trials (mesulergine) | Recent Studies (post-2010) (mesulergine) |
|---|---|---|---|---|---|
| 9 | 0 | 2 | 265 | 10 | 28 |
| Protein | Taxonomy | 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine (IC50) | mesulergine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0019 | |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | 0.205 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.0021 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0052 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.0021 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Budillon, A; Caliendo, G; De Angelis, F; Di Cintio, A; Di Gennaro, E; Esposito, A; Fiorino, F; Frecentese, F; Incisivo, GM; Magli, E; Massarelli, P; Nencini, C; Perissutti, E; Santagada, V; Severino, B | 1 |
1 other study(ies) available for 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine and mesulergine
| Article | Year |
|---|---|
Synthesis of 1-naphtylpiperazine derivatives as serotoninergic ligands and their evaluation as antiproliferative agents.
Topics: Antineoplastic Agents; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Ligands; Male; Molecular Structure; Naphthalenes; Piperazines; Prostatic Neoplasms; Receptor, Serotonin, 5-HT1A; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 2011 |